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To the Editor:
Endogenous adenosine is an important mediator of ischae-
mic preconditioning and postconditioning. The protective
effect of ischaemic preconditioning is dependent on
activation of adenosine A1 receptors in the first few minutes
of reperfusion [1]. In contrast, the infarct size-limiting
effect of ischaemic postconditioning is mediated by the
activation of adenosine A2A and A2B receptors at the time
of reperfusion [2, 3]. Paradoxically, although the cardio-
protective effect of preconditioning and postconditioning
are critically dependent on adenosine receptor stimulation
immediately after reperfusion, several research groups
could not demonstrate an infarct size-limiting effect of
administration of exogenous adenosine at the moment of
reperfusion [4–6]. A possible explanation is that the pre-
and postconditioning stimuli increase the sensitivity of a
specific adenosine receptor sub-type. Indeed, this mecha-
nism was recently proposed for the adenosine A2B receptor
[7]. The A2B receptor has a Km value for adenosine that is
much higher than the endogenous adenosine concentration
reached during ischaemia. Kuno et al have recently shown
in the rabbit heart that brief preconditioning ischaemia
markedly lowered the threshold for an adenosine A2B
agonist to increase the phosphorylation of the kinases, Akt
and Erk1/2 [7].
In this study, we test the hypothesis that ischaemic
preconditioning also increases the sensitivity of the adeno-
sine A1 receptor at the time of myocardial reperfusion, and
that ischaemic postconditioning increases the sensitivity of
the adenosine A2A receptor, using an isolated perfused rat
heart model. As adenosine A1 receptor stimulation has a
negative inotropic effect and adenosine A2A receptor
stimulation induces coronary vasodilation, we used heart
rate and coronary flow as read-out parameters for adenosine
A1 and A2A receptor sensitivity, respectively. Male Sprague-
Dawley rats were obtained from the Biological Services Unit
of University College London (United Kingdom). All
experiments were conducted in accordance with UK Home
Office Guide on the Operation of Animal (Scientific
Procedures) Act of 1986. After anaesthesia with pentobarbi-
tal, hearts were excised and mounted on a constant pressure
(80 mmHg) Langendorff-apparatus and perfused with mod-
ified Krebs–Henseleit bicarbonate buffer (gassed with 95%
O2 /5 %C O 2,p H 7 . 3 5 –7.5). Heart rate and coronary flow
were monitored at regular intervals. To study the sensitivity
of the adenosine A1 receptor, hearts were perfused with
incremental concentrations of the selective A1 receptor
agonist 2-chloro-N6-cyclopentyl-adenosine (CCPA) (10
−10
to 10
−6 mmol/l) for 5 min per concentration. Heart rate was
measured in the last minute of perfusion of each concentra-
tion and compared to the baseline heart rate. To study the
sensitivity of the A2A receptor, the hearts were perfused with
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DOI 10.1007/s10557-009-6196-1the selective A2A receptor agonist CGS21680 (10
−10 to 10
−6
mmol/l) and coronary flow rate was measured in the last
minute of each concentration. These measurements were
performed at baseline (after 30 min of equilibration), at
20 min reperfusion after 35 min of regional ischaemia in
control hearts and hearts treated with a standard ischaemic
preconditioning protocol (two cycles of 5 min of global
ischaemia and reperfusion) or a standard ischaemic post-
conditioning protocol (6 cycles of 10 s of global ischaemia
and reperfusion). The measurements were performed 20 min
after reperfusion to allow the heart rate and coronary flow to
return to baseline values after the ischaemic insult.
Perfusion with CCPA dose-dependently lowered heart
rate (Fig. 1). This reduction in heart rate was similar at
baseline and at 20 min myocardial reperfusion (data not
shown), and was not affected by preconditioning (P=0.9
and P=0.4 for comparison of EC50 and Vmax values,
respectively, univariate analysis of variance). Perfusion
with CGS21680 dose-dependently increased coronary flow
at baseline (Fig. 2). However, after ischaemia, this effect
was blunted, and did not differ between the postcondition-
ing and control groups (P=0.8, ANOVA for repeated
measures on absolute flow values).
In conclusion, the present study demonstrates that
ischaemic preconditioning and postconditioning do not
increase the sensitivity of the adenosine A1 and A2A
receptor, respectively. Therefore, this mechanism does not
explain the apparent discrepancy that the cardioprotective
effect of ischaemic pre-, and postconditioning is critically
dependent on adenosine receptor sub-type stimulation
during reperfusion, whereas administration of exogenous
adenosine during reperfusion does not reduce infarct size.
An alternative explanation could relate to the role of the
coronary endothelium in the metabolism of adenosine. As
the endothelium acts as a strong metabolic barrier for
circulating adenosine by its rapid uptake and intracellular
degradation, intravascular administration of adenosine does
not affect the myocardial interstitial adenosine concentra-
tion, whereas ischaemic pre- and postconditioning do also
increase the interstitial concentration [8]. Additional studies
are needed to test this hypothesis.
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Fig. 1 The heart rate response to perfusion with incremental concen-
trations of CCPA at baseline (before any intervention, ∆, n=5), after
35 min of regional ischaemia and 20 min of myocardial reperfusion
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Fig. 2 The coronary flow rate response to perfusion with incremental
concentrationofCGS21680atbaseline(beforeanyintervention,∆,n=5),
after 35 min of regional ischaemia and 20 min reperfusion (■, n=5),and
after 35 min of ischaemia and 20 min of reperfusion incorporating the
ischaemic postconditioning protocol, ○, n=5)
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